首页> 外国专利> (-)-rel-(1R, 6R,1'R) -1-(1'-Iodoethyl)-9-oxabicyclo4.3.0nonan-8-one and method of obtaining (-)-rel-(1R,6R,1'R)-1-(1'-iodoethyl)-9-oxabicyclo4.3.0nonan-8-one

(-)-rel-(1R, 6R,1'R) -1-(1'-Iodoethyl)-9-oxabicyclo4.3.0nonan-8-one and method of obtaining (-)-rel-(1R,6R,1'R)-1-(1'-iodoethyl)-9-oxabicyclo4.3.0nonan-8-one

机译:(-)-rel-(1R,6R,1'R)-1-(1'-碘乙基)-9-氧杂环[4.3.0] nonan-8-及其获得方法(-)-rel-(1R ,6R,1'R)-1-(1'-碘乙基)-9-氧杂双环[4.3.0] nonan-8-one

摘要

The subject of the notification is optically active (-)-rel-(1R,6R,1'R)-1-(1'-iodoethyl)-9-oxabicyclo[4.3.0]nonan-8-one of the formula 2,which may be used in the pharmacopoeia as an anticancer compound. The notification also covers the optically active (-)-rel-(1R,6R,1'R)-1-(1'-iodoethyl)-9-oxabicyclo[4.3.0]nonan-8-one, which means that 1-formula ethylene-cyclohexyl(2)-(2'-ethylene-cyclohexyl)acetic acid undergoes a yodolactonisation reaction by receiving (-)-rel-(1R,6R, 1'R)-1-(1'-iodoethyl)-9-oxabicyclo[4.3.0]nonan-8-one with formula 2, which is then purified by a column chromatography method.
机译:通知的主题是旋光的(-)-rel-(1R,6R,1'R)-1-(1'-碘乙基)-9-氧杂双环[4.3.0] nonan-8-式2之一,可以在药典中用作抗癌化合物。该通知还涉及旋光性(-)-rel-(1R,6R,1'R)-1-(1'-碘乙基)-9-氧杂环[4.3.0] nonan-8-,这意味着1式-乙烯-环己基(2)-(2'-乙烯-环己基)乙酸通过接受(-)-rel-(1R,6R,1'R)-1-(1'-碘乙基)-而发生碘内酯化反应具有式2的9-氧杂双环[4.3.0]壬南-8-酮,然后通过柱色谱法纯化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号